Minimal effects on immune parameters following chronic anti-TGF-β monoclonal antibody administration to normal mice

Immunopharmacology and Immunotoxicology

Volumn 25, Issue 2, 2003, Pages 235-257

  Ruzek, Melanie C ^a   Hawes, Michael ^a   Pratt, Bruce ^a   McPherson, John ^a   Ledbetter, Steve ^a   Richards, Susan M ^a   Garman, Richard D ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

Antibody; Immune system; Mice; Transforming growth factor beta (TGF )

Indexed keywords

IMMUNOGLOBULIN A; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE PROLIFERATION; MALE; MEMORY CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PLEIOTROPY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; AUTOANTIBODIES; CYTOKINES; FEMALE; IMMUNOGLOBULINS; INJECTIONS, INTRAPERITONEAL; KILLER CELLS, NATURAL; LYMPHOID TISSUE; MALE; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0037570729     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120020473     Document Type: Article

References (52)

1. Letterio, J.J.; Roberts, A.B. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 1998, 16, 137-161.
2. Kehrl, J.H.; Taylor, A.S.; Delsing, G.A.; Roberts, A.B.; Sporn, M.B.; Fauci, A.S. Further studies of the role of transforming growth factor-beta in human B cell function. J. Immunol. 1989, 143, 1868-1874.
3. Su, H.C.; Leite-Morris, K.A.; Braun, L.; Biron, C.A. A role for transforming growth factor-beta 1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus. J. Immunol. 1991, 147, 2717-2727.
4. Malygin, A.M.; Meri, S.; Timonen, T. Regulation of natural killer cell activity by transforming growth factor-beta and prostaglandin E2. Scand. J. Immunol. 1993, 37, 71-76.
5. Ding, A.; Nathan, C.F.; Graycar, J.; Derynck, R.; Stuehr, D.J.; Srimal, S. Macrophage deactivating factor and transforming growth factor-beta 1, -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J. Immunol. 1990, 145, 940-944.
6. Ishizaka, S.; Yoshikawa, M.; Tsujii, T. Immunoregulatory effects of transforming growth factor-beta in a prolonged period of culture. Cell. Immunol. 1992, 139, 239-247.
7. Nelson, B.J.; Ralph, P.; Green, S.J.; Nacy, C.A. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1. J. Immunol. 1991, 146, 1849-1857.
8. Cerwenka, A.; Swain, S.L. TGF-β1: immunosuppressant and viability factor for T lymphocytes. Microbes Infect. 1999, 1, 1291-1296.
9. Wahl, S.M.; Orenstein, J.M.; Chen, W. TGF-beta influences the life and death decisions of T lymphocytes. Cytokine Growth Factor Rev. 2000, 11, 71-79.
10. Schiott, A.; Sjogren, H.O.; Lindvall, M. The three isoforms of transforming growth factor-beta co-stimulate rat T cells and inhibit lymphoctye apoptosis. Scand. J. Immunol. 1998, 48, 371-378.
11. Zhang, X.; Giangrecco, L.; Broome, H.E.; Dargan, C.M.; Swain, S.L. Control of CD4 effector fate: transforming growth factor beta1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J. Exp. Med. 1995, 182, 699-709.
12. Genestier, L.; Kasibhatla, S.; Brunner, T.; Green, D.R. Transforming growth factor betal inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc. J. Exp. Med. 1999, 189, 231-239.
13. Ashcroft, G.S. Bidirectional regulation of macrophage function by TGF-beta. Microbes Infect. 1999, 1, 1275-1282.
14. Cottrez, F.; Groux, H. Regulation of TGF-β response during T cell activation is modulated by IL-10. J. Immunol. 2001, 167, 773-778.
15. Ludvicksson, B.R.; Seegers, D.; Resnick, A.S.; Strober, W. The effect of TGF-β1 on immune responses of naïve versus memory CD4+ Th1/Th2 T cells. Eur. J. Immunol. 2000, 30, 2101-2111.
16. Hoehn, P.; Goedert, S.; Germann, T.; Koelsch, S.; Jin, S.; Palm, N.; Ruede, E.; Schmitt, E. Opposing effects of TGF-β2 on the Th1 cell development of naïve CD4+ T cells isolated from different mouse strains. J. Immunol. 1995, 155, 3788-3793.
17. Corradin, S.B.; Buchmuller-Rouiller, Y.; Smith, J.; Suardet, L.; Mauel, J. Transforming growth factor beta 1 regulation of macrophage activation depends on the triggering stimulus. J. Leukoc. Biol. 1993, 54, 423-429.
18. McKarns, S.C.; Kaminski, N.E. TGF-beta 1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes. Immunopharmacology 2000, 48, 101-115.
19. Shull, M.M.; Ormsby, I.; Kier, A.B.; Pawlowski, S.; Diebold, R.J.; Yin, M.; Allen, R.; Sidman, C.; Proetzel, G.; Calvin, D.; Annunziata, N.; Doetschman, T. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359, 693-699.
20. Kulkarni, A.B.; Huh, C.G.; Becker, D.; Geiser, A.; Lyght, M.; Flanders, K.C.; Roberts, A.B.; Sporn, M.B.; Ward, J.M.; Karlsson, S. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory responses and early death. Proc. Natl Acad. Sci. USA 1993, 90, 770-774.
21. Dang, H.; Geiser, A.G.; Letterio, J.J.; Nakabayashi, T.; Kong, L.; Fernandes, G.; Talal, N. SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-β knockout mice. J. Immunol. 1995, 155, 3205 - 3212.
22. McCartney-Francis, N.L.; Mizel, D.E.; Redman, R.S.; Frazier-Jessen, M.; Panek, R.B.; Kulkarni, A.B.; Ward, J.M.; McCarthy, J.B.; Wahl, S.M. Autoimmune Sjogren's-like lesions in salivary glands of TGF-β1-deficient mice are inhibited by adhesion-blocking peptides. J. Immunol. 1996, 157, 1306-1312.
23. Christ, M.; McCartney-Francis, N.L.; Kulkarni, A.B.; Ward, J.M.; Mizel, D.E.; Mackall, C.L.; Gress, R.E.; Hines, K.L.; Tian, H.; Karlsson, S.; Wahl, S.M. Immune dysregulation in TGF-β1-deficient mice. J. Immunol. 1994, 153, 1936-1946.
24. Chen, W.; Jin, W.; Tian, H.; Sicurello, P.; Frank, M.; Orenstein, J.M.; Wahl, S.M. Requirement of transforming growth factor β1 in controlling T cell apoptosis. J. Exp. Med. 2001, 194, 439-453.
25. Van Ginkel, F.W.; Wahl, S.M.; Kearney, J.F.; Kweon, M.N.; Fujihashi, K.; Burrows, P.D.; Kiyono, H.; McGhee, J.R. Parial IgA-deficiency with increased Th2-type cytokines in TGF-beta1 knockout mice. J. Immunol. 1999, 163, 1951-1957.
26. Geiser, A.G.; Letterio, J.J.; Kulkarni, A.B.; Karlsson, S.; Roberts, A.B.; Sporn, M.B. Transforming growth factor β1 (TGF-β1) controls expression of major histocompatibility genes in the post natal mouse: aberrant histocompatibility antigen expression in the pathogenesis of TGF-β1 null mouse phenotype. Proc. Natl Acad. Sci. USA 1993, 90, 9944-9948.
27. Nakabayashi, T.; Lettterio, J.J.; Geiser, A.G.; Kong, L.; Ogawa, N.; Zhao, W.; Koike, T.; Fernandes, G.; Dang, H.; Talal, N. Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-β1 knockout mice. MHC class II is a factor in the pathogenesis of TGFβ1 knockout mice. J. Immunol. 1997, 158, 5527-5535.
28. Kobayashi, S.; Yoshida, K.; Ward, J.M.; Letterio, J.J.; Longenecker, G.; Yaswen, L.; Mittleman, B.; Mozes, E.; Roberts, A.B.; Karlsson, S.; Kulkarni, A.B. β2-microglobulin-deficient background ameliorates lethal phenotype of TGF-β1 null mouse. J. Immunol. 1999, 163, 4013-4019.
29. Diebold, R.J.; Eis, M.J.; Yin, M.; Ormsby, I.; Boivin, G.P.; Darrow, B.J.; Saffitz, J.E.; Doetschman, T. Early-onset mulifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc. Natl Acad. Sci. 1995, 92, 12215-12219.
30. Gorelik, L.; Flavell, R.A. Abrogation of TGFbeta signalling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000, 12, 171-181.
31. Lucas, P.J.; Kim, S.-J.; Melby, S.J.; Gress, R.E. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J. Exp. Med. 2000, 191, 1187-1196.
32. Cazac, B.B.; Roes, J. TGF-β receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 2000, 13, 443-445.
33. Coffman, R.L.; Lebman, D.A.; Shrader, B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide stimulated murine B lymphocytes. J. Exp. Med. 1989, 170, 1039-1044.
34. Van Vlasselaer, P.; Punnonen, J.; De Vries, J.E. Transforming growth factor-beta directs IgA switching in human B cells. J. Immunol. 1992, 148, 2062-2067.
35. Strockbine, N.A.; Marques, L.R.; Holmes, R.K.; O'Brien, A.D. Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect. Immun. 1985, 50, 695-700.
36. Danielpour, D.; Dart, L.L.; Flanders, K.C.; Roberts, A.B.; Sporn, M.B. Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta1 and TGF-beta 2) secreted by cells in culture. J. Cell. Physiol. 1989, 138, 79-86.
37. Coligan, J.E.; Kruisbeek, A.M.; Margulies, D.H.; Shevach, E.M.; Strober, W. Current Protocols in Immunology; John Wiley & Sons, Inc.: New York, 2002.
38. Pisetsky, D.S.; McCarty, G.A.; Peters, D.V. Mechanisms of autoantibody production in autoimmune MRL mice. J. Exp. Med. 1980, 152, 1302-1310.
39. Gorham, J.D.; Lin, J.T.; Sung, J.L.; Rudner, L.A.; French, M.A. Genetic regulation of autoimmune disease: BALB/c background TGF-β1-deficient mice develop necroinflammatory IFN-γ-dependent hepatitis. J. Immunol. 2001, 166, 6413-6422.
40. Plum, J.; Smedt, M.; Leclercq, G.; Vandekerckhove, B. Influence of TGF-beta on murine thymocyte development in fetal thymus organ culture. J. Immunol. 1995, 154, 5789-5798.
41. Lai, L.; Alaverdi, N.; Maltais, L.; Morse, H.C., III. Mouse cell surface antigens: nomenclature and immunophenotyping. J. Immunol. 1998, 160, 3861-3868.
42. Clark, E.A.; Shu, G.L.; Luscher, B.; Draves, K.E.; Banchereau, J.; Ledbetter, J.A.; Valentine, M.A. Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals. J. Immunol. 1989, 143, 3873-3880.
43. Biron, C.A.; Sonnenfeld, G.; Welsh, R.M. Interferon induces natural killer cell blastogenesis in vivo. J. Leukoc. Biol. 1984, 35, 31-37.
44. Vermes, I.; Haanen, C.; Steffens-Nakken, H.; Reutelingsperger, C. Flow cytometric detection of phosphatidyldserine expression on early apoptotic cells using fluorescein labeled Annexin V. J. Immunol. Methods 1995, 184, 39-51.
45. Shores, E.W.; Eisenberg, R.A.; Cohen, P.L. Role of the Sm antigen in the generation of anti-Sm autoantibodies in the SLE-prone MRL mouse. J. Immunol. 1986, 136, 3662-3667.
46. Kanai, Y.; Fujiwara, M. Naturally occurring antibodies to poly (ADP-ribose) in autoimmune MRL/Mp-lpr/lpr mice. Clin. Exp. Immunol. 1985, 59, 132-138.
47. Yang, Y.; Dukhanina, O.; Tang, B.; Mamura, M.; Letterio, J.J.; MacGregor, J.; Patel, S.C.; Khozin, S.; Liu, Z.; Green, J.; Anver, M.R.; Merlino, G.; Wakefield, L.M. Lifetime exposure to a soluble TGF-β antagonists protects mice against metastases without adverse side effects. J. Clin. Investig. 2002, 109, 1607-1615.
48. Kaartinen, V.; Voncken, J.W.; Shuler, C.; Warburton, D.; Bu, D.; Heisterkamp, N.; Groffen, J. Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 1995, 11, 415-421.
49. Proetzel, G.; Pawlowski, S.A.; Wiles, M.V.; Yin, M.; Boivin, G.P.; Howles, P.N.; Ding, J.; Ferguson, M.W.J.; Doetschman, T. Transforming growth factor-β3 is required for secondary palate fusion. Nat. Genet. 1995, 11, 409-414.
50. Sanford, L.P.; Ormsby, I.; Gittenberger-de Groot, A.C.; Sariola, H.; Friedman, R.; Boivin, G.P.; Cardell, E.L.; Doetschman, T. TGF-β2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development 1997, 124, 2659-2670.
51. Fernandez, T.; Amoroso, S.; Sharpe, S.; Jones, G.M.; Bliskovski, V.; Kovalchuk, A.; Wakefield, L.M.; Kim, S.; Potter, M.; Letterio, J.J. Disruption of transforming growth factor β signaling by a novel ligand-dependent mechanism. J. Exp. Med. 2002, 195, 1247-1255.
52. Longenecker, G.; Thyagarajan, T.; Nagineni, C.N.; Flanders, K.C.; Factor, V.; Miller, G.; Ward, J.M.; Nalca, A.; Rangnekar, V.M.; Thorgeirsson, S.; Kulkarni, A.B. Endocrine expression of the active form of TGF-β1 in the TGF-β1 null mice fails to ameliorate lethal phenotype. Cytokine 2002, 18, 43-50.